Drug Channels

APRIL 30, 2021

Today’s guest post comes from Natalie Tyler, Director of Pharmacy Operations & Strategy at ConnectiveRx. Natalie discusses how non-commercial pharmacies boost patient access and adherence to specialty therapies. They also help physicians deliver better care.

Pharmacy 52

Pharmacy Therapies Drugs 52

Drug Channels

APRIL 8, 2022

He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment. To learn more about CoAssist and AssistRx specialty therapy initiation and patient support services, click here to schedule a meeting with AssistRx at the Asembia Specialty Pharmacy Summit on May 2-5, 2022.

Specialty Pharmacies 96

Specialty Pharmacies Production Pharmacy Therapies 96

Drug Channels

APRIL 14, 2023

Edward discusses how a technology-first approach automates manual processes for therapy initiation. He argues that such an approach can increase patient adherence, speed access to therapy, and improve the healthcare providers’ workflow. Read on for Edward’s insights.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Therapies Drugs 98

Drug Channels

APRIL 28, 2023

She describes how human care plus an innovative, technology-driven patient support solution can help patients start therapy and get on the road to recovery. To learn more about CoverMyMeds’ specialty therapy solutions , visit Booth 1519 at Asembia's Specialty Pharmacy Summit in Las Vegas, April 30-May 4, 2023.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Therapies Drugs 98

Drug Channels

JANUARY 27, 2023

Saket discusses market access and contracting strategies for medical benefit products when pharmacy benefit biosimilar therapies launch. Today’s guest post comes from Saket Patel, Consultant, Advisory Services at MMIT. He then describes how to automate formulary and medical policies to protect manufacturers from overpayment.

Biosimilars 97

Biosimilars Pharmacy Therapies Production 97

Drug Channels

MARCH 11, 2022

Learn more about AssistRx’s specialty therapy initiation and patient support services at Asembia's Specialty Pharmacy Summit on May 2-5, 2022. Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Click here to schedule your meeting. Read on for Stacey’s insights.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Therapies Marketing 97

Drug Channels

NOVEMBER 17, 2023

Maria discusses the challenges patients and healthcare providers face accessing specialty therapies. She introduces us to ACTICS ® eAccess , EVERSANA’s technology platform for electronic prior authorization and benefits verification that can be used for both the pharmacy benefit and the medical benefit.

Pharmacy 97

Pharmacy Therapies Drugs 97

Drug Channels

MARCH 10, 2023

Stacey discusses digital hubs and the affordability advantages they offer both patients on specialty therapies and their health care providers. To learn more, click here to schedule a meeting with AssistRx at Asembia’s Specialty Pharmacy Summit on April 30 to May 4, 2023.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Therapies Marketing 98

Drug Channels

AUGUST 5, 2022

She argues that manufacturers adopt an electronic health record-based solution to facilitate access to therapies, from the point of prescription through the point of dispensing at the pharmacy. Karina discusses the challenges health care providers and patients face in their quest to secure prior authorizations from payers.

Pharmacy 98

Pharmacy Therapies Marketing Drugs 98

Drug Channels

NOVEMBER 24, 2020

In this issue: Rebate rule redux Most Favored Nation and healthcare benchmarking Amazon’s pharmacy customer opportunity Drug spending realities updated GPO consolidation Plus, I congratulate Dirk Rodgers of RxTrace on his retirement. P.S. Join the more than 10,600 followers of my curated links published on @DrugChannels on Twitter.

Pharmacy 52

Pharmacy Specialty Pharmacies Biosimilars Drugs 52

Drug Patent Watch

DECEMBER 9, 2024

The Essence of Pharmacognosy: Nature’s Pharmacy Unveiled Imagine walking through a lush rainforest, surrounded by countless plant species. While the compound itself couldn’t be patented, various derivatives and combination therapies have been patented, allowing for continued development and distribution.

Drugs 96

Drugs Drug Development Pharmaceuticals Production 96

Drug Channels

MAY 22, 2023

WHAT YOU WILL LEARN As expensive specialty therapies come to dominate drug spending, pharmaceutical manufacturers are paying a growing share of patents’ out-of-pocket costs for these prescriptions. Pharmacies and Pharmacy Benefit Managers. This event is part of The Drug Channels 2023 Video Webinar Series.

Pharmacy 97

Pharmacy Drugs Marketing Therapies 97

Drug Channels

FEBRUARY 23, 2021

In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! Plus, entrepreneurial pharmacy owner Dave Marley demonstrates the power of innovation. Sometimes, the little guy wins big.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Independent Pharmacies 52

Drug Channels

MAY 9, 2023

Last week, Paula and I had the pleasure of attending Asembia’s 2023 Specialty Pharmacy Summit at the wonderful Wynn Las Vegas. As I do every year, I will violate Vegas code and tell you what happened there.

Specialty Pharmacies 98

Specialty Pharmacies Marketing Pharmacy Drugs 98

Drug Channels

AUGUST 13, 2021

Stacey discusses how a patient support vendor can help specialty pharmacy patients attain prior authorizations and access critical therapies. Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Therapies Marketing 75

Drug Channels

OCTOBER 17, 2022

Don’t miss the chance to unite with colleagues and master the complexities of pharmacy and distribution models to accelerate patient access!

Biosimilars 75

Biosimilars Pharmacy Therapies Production 75

Drug Channels

JUNE 5, 2023

Join peers this August to discover the evolving specialty pharmacy marketplace, build multi-stakeholder partnerships, and explore frameworks to inform your 2024 distribution and patient service strategies.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy Biosimilars Compliance 74

Drug Channels

SEPTEMBER 18, 2020

Ela discusses the important role independent specialty pharmacies play in educating payers, supporting patients, and ultimately getting potentially life-saving therapies into the hands of patients. Today’s guest post comes from Ela Lourido, Vice President of Business Development at Biologics by Mckesson.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Drugs Therapies 40

Drug Channels

APRIL 16, 2021

Jeff discusses aspects of our drug pricing system that lead to decreased new and refill prescription volume, higher out-of-pocket costs for patients, and therapy abandonment. Today’s guest post comes from Jeff Spafford, President and CEO at AssistRx.

Production 52

Production Pharmacy Therapies Drugs 52

NIH Director's Blog: Drug Discovery

AUGUST 21, 2014

But these researchers from the University of Florida College of Pharmacy in Gainesville are out to discover something far more valuable to patients than sunken treasure: marine life with chemical compounds that may provide the basis for new treatments and cures.

Pharmacy 52

Pharmacy Drugs Science Therapies 52

Fierce BioTech

JUNE 1, 2023

Non-traditional visits, such as therapy sessions and services provided at pharmacies and infusion centers, are not cleanly captured in claims data. This results in skewed forecasting, market sizing, and targeting efforts. However, there are novel ways to capture those visits using high-quality provider affiliations data.

Pharmacy 52

Pharmacy Therapies Marketing 52

Drug Channels

MAY 31, 2024

Jan then highlights how the right vendor can help overcome these challenges for both pharmacy and medical benefit products. To learn more about AssistRx’s solutions for medical benefit products, read their latest case study: eMedical Benefit Verification: Improving Speed to Therapy and Patient & HCP Experiences.

Pharmacy 52

Pharmacy Science Therapies Production 52

The Pharma Data

AUGUST 28, 2020

The drug is being developed and tested by researchers at the University of Illinois at Chicago and is a type of hormone therapy, which targets oestrogen receptor-positive types of breast cancer. The doses of the therapy given were in line with therapeutic levels that are standard in hormone therapy. Conor Kavanagh.

Disease 52

Disease Trials Clinical Trials Pharmacy 52

Drug Channels

SEPTEMBER 21, 2020

This important event convenes key stakeholders including manufacturers, specialty pharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and optimal reimbursement. Arquette, R.Ph.,

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Production 52

Drug Channels

JUNE 26, 2023

View the agenda for Health Systems & Pharma Partnering 2023 to see the complete picture – the program, speakers, and more, and visit www.informaconnect.com/health-systems-partnering for further details and to register.

Biosimilars 75

Biosimilars Pharmacy Science Therapies 75

Drug Channels

JANUARY 12, 2021

Once again, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have increased the number of drugs they have excluded from their standard formularies. . I also highlight the expansion of exclusions into major specialty therapy classes.

Pharmacy 52

Pharmacy Drugs Therapies Production 52

Advarra

MARCH 6, 2025

Furthermore, Advarras IRB includes hundreds of expert members, many of whom bring expertise and experience in several therapeutic areas and disciplines, including oncology, bioethics, investigational pharmacy, internal medicine, psychology, physiology, radiology, public health, pediatrics, nursing, and social and behavioral science.

Clinical Research 52

Clinical Research Research Clinical Trials Bioethics 52

PPD

MAY 18, 2023

PPD experts have long been trailblazers in this field, from our clinical research unit in Orlando to new programs that partner with pharmacies to recruit candidates more effectively. By recognizing which persons with dementia at a given pharmacy are taking the standard dementia medication, we can do a targeted recruitment campaign.

Clinical Trials 86

Clinical Trials Trials Clinical Research Doctors 86

Drug Channels

MARCH 22, 2021

Once again, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have increased the number of drugs they have excluded from their standard formularies. . I also highlight the expansion of exclusions into major specialty therapy classes.

Pharmacy 52

Pharmacy Drugs Therapies Production 52

DrugBank

SEPTEMBER 26, 2024

This is because biosimilars are not new drugs but highly similar versions of already approved therapies with established safety and efficacy profiles. One key challenge is the development of biosimilars for complex biologics, such as monoclonal antibodies used in cancer treatment and gene therapies.

Biosimilars 98

Biosimilars Clinical Trials Production FDA 98

Drug Target Review

JUNE 13, 2023

Don’t miss your chance to embrace the future of cellular therapies – dive in now! Immerse yourself in exclusive content, including articles on cutting-edge cell line development and insightful interviews with industry experts. Download your FREE copy today. This eBook is supported by BioTechne.

Engineering 52

Engineering Pharmacy Drug Development Therapies 52

Alta Sciences

OCTOBER 30, 2023

TOP NONCLINICAL SCIENTIFIC RESOURCES eBook : Safety Assessment for Ophthalmic Products Designing preclinical studies for ocular therapies take a lot of deliberation. The Altascientist : Issue No. Read or listen now. Listen here.

Science 52

Science Clinical Trials Pharmacokinetics Pharmacy 52

Drug Channels

AUGUST 7, 2020

Today’s guest post comes from Rob Brown, VP/GM of RxCrossroads by McKesson Program Pharmacy. Rob reviews how COVID-19 is changing patient access and adherence to specialty therapies. To learn more, visit www.McKesson.com/RxCrossroads.

Pharmacy 40

Pharmacy Therapies Drugs 40

The Pharma Data

OCTOBER 19, 2020

20, 2020 /PRNewswire/ — Abarca , a pharmacy benefit manager (PBM) that is disrupting the industry with a new approach to technology and business practices released a new case study detailing a value-based agreement with Biogen Inc. It started by redefining pharmacy benefits, but this is just the beginning. organization.

Production 40

Production Pharmacy Pharmaceutical Companies Therapies 40

Fierce BioTech

DECEMBER 27, 2023

Key Discussion Points: Examine the benefits of direct-to-patient cash options and the demand for alternative access pathways that increase access and create the shortest path between patient and therapy. Discover the value of a white-labeled pharmacy from a marketing messaging and operational perspective.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmacy Therapies Pharmaceuticals 52

The Pharma Data

DECEMBER 28, 2020

Pharmacy-driven interventions can be included in inpatient ASPs. Outpatient stewardship can focus on judicious antibiotic use and can emphasize use of the narrowest-spectrum antibiotics for the shortest duration of therapy to adequately treat infections. “Consistent with the U.S.

Pharmacy 52

Pharmacy Disease Therapies 52

The Pharma Data

MARCH 27, 2021

Dr. Martin received his MD at the University of Medicine and Pharmacy Timisoara, Romania. Throughout my career, I have been focused on translating scientific discoveries into the development of potential new therapies with the goal of helping people with unmet medical needs. Dr. Lee joined Gilead in 1991.

Science 52

Science Research Clinical Development Pharmacy 52